Work

Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence

Year: 2024
Type: article
Abstract: adverse events,
Source: eJHaem
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,600
OpenAlex ID: W4404045069
FWCI: 0.471
Cites: 8
Cited by: 2
Related to: 10